SI2791129T1 - Postopek za pripravo estrov (5-fluoro-2-metil-3-kinolin-2-ilmetilindol-1-il)-ocetne kisline - Google Patents

Postopek za pripravo estrov (5-fluoro-2-metil-3-kinolin-2-ilmetilindol-1-il)-ocetne kisline

Info

Publication number
SI2791129T1
SI2791129T1 SI201230408T SI201230408T SI2791129T1 SI 2791129 T1 SI2791129 T1 SI 2791129T1 SI 201230408 T SI201230408 T SI 201230408T SI 201230408 T SI201230408 T SI 201230408T SI 2791129 T1 SI2791129 T1 SI 2791129T1
Authority
SI
Slovenia
Prior art keywords
quinolin
indol
ylmethyl
fluoro
methyl
Prior art date
Application number
SI201230408T
Other languages
English (en)
Slovenian (sl)
Inventor
Jacques Tonnel
Tony Pintus
Alain Burgos
Original Assignee
Atopix Therapeutics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atopix Therapeutics Limited filed Critical Atopix Therapeutics Limited
Publication of SI2791129T1 publication Critical patent/SI2791129T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI201230408T 2011-12-15 2012-12-14 Postopek za pripravo estrov (5-fluoro-2-metil-3-kinolin-2-ilmetilindol-1-il)-ocetne kisline SI2791129T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201121557A GB201121557D0 (en) 2011-12-15 2011-12-15 Process
EP12805725.4A EP2791129B1 (en) 2011-12-15 2012-12-14 Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid esters
PCT/GB2012/000903 WO2013088108A1 (en) 2011-12-15 2012-12-14 Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid esters

Publications (1)

Publication Number Publication Date
SI2791129T1 true SI2791129T1 (sl) 2016-02-29

Family

ID=45560499

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201230408T SI2791129T1 (sl) 2011-12-15 2012-12-14 Postopek za pripravo estrov (5-fluoro-2-metil-3-kinolin-2-ilmetilindol-1-il)-ocetne kisline

Country Status (27)

Country Link
US (1) US9102658B2 (enExample)
EP (1) EP2791129B1 (enExample)
JP (2) JP6300277B2 (enExample)
KR (1) KR102018929B1 (enExample)
CN (1) CN104114548B (enExample)
AU (1) AU2012351341B2 (enExample)
BR (1) BR112014014604B1 (enExample)
CA (1) CA2859281C (enExample)
CY (1) CY1117087T1 (enExample)
DK (1) DK2791129T3 (enExample)
EA (1) EA026617B1 (enExample)
ES (1) ES2557762T3 (enExample)
GB (1) GB201121557D0 (enExample)
HR (1) HRP20151422T1 (enExample)
HU (1) HUE028257T2 (enExample)
IL (1) IL233132A (enExample)
ME (1) ME02348B (enExample)
MX (1) MX342273B (enExample)
PL (1) PL2791129T3 (enExample)
PT (1) PT2791129E (enExample)
RS (1) RS54523B1 (enExample)
SG (1) SG11201402798RA (enExample)
SI (1) SI2791129T1 (enExample)
SM (1) SMT201500327B (enExample)
UA (1) UA111868C2 (enExample)
WO (1) WO2013088108A1 (enExample)
ZA (1) ZA201404246B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201103837D0 (en) 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
GB201121557D0 (en) * 2011-12-15 2012-01-25 Oxagen Ltd Process
GB201322273D0 (en) * 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
EP3902794A1 (en) 2018-12-27 2021-11-03 Chiesi Farmaceutici S.p.A. Process for preparing spherical agglomerates of timapiprant
CN111978245A (zh) * 2020-09-15 2020-11-24 上海毕得医药科技有限公司 一种3-氟-2-异丁基吡啶的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1675826A1 (en) 2003-10-14 2006-07-05 Oxagen Limited Compounds having crth2 antagonist activity
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
GB0504150D0 (en) 2005-03-01 2005-04-06 Oxagen Ltd Microcrystalline material
GB0505048D0 (en) 2005-03-11 2005-04-20 Oxagen Ltd Compounds with PGD antagonist activity
US7188489B2 (en) 2005-04-12 2007-03-13 Martello Russell A Portable air conditioner
GB0605743D0 (en) * 2006-03-22 2006-05-03 Oxagen Ltd Salts with CRTH2 antagonist activity
EP2046740B1 (en) 2006-07-22 2012-05-23 Oxagen Limited Compounds having crth2 antagonist activity
US20110124683A1 (en) 2007-11-13 2011-05-26 Oxagen Limited Use of CRTH2 Antagonist Compounds
NZ587251A (en) 2008-01-18 2011-12-22 Oxagen Ltd Indole derivatives having CRTH2 antagonist activity
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
EP2240444A1 (en) 2008-01-22 2010-10-20 Oxagen Limited Compounds having crth2 antagonist activity
US20130052190A1 (en) 2011-02-22 2013-02-28 Oxagen Limited CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions
GB201103837D0 (en) 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
GB201121557D0 (en) 2011-12-15 2012-01-25 Oxagen Ltd Process
WO2013088109A1 (en) 2011-12-16 2013-06-20 Oxagen Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis

Also Published As

Publication number Publication date
US20140350264A1 (en) 2014-11-27
CY1117087T1 (el) 2017-04-05
WO2013088108A1 (en) 2013-06-20
CA2859281A1 (en) 2013-06-20
PL2791129T3 (pl) 2016-05-31
KR20140113927A (ko) 2014-09-25
KR102018929B1 (ko) 2019-09-05
IL233132A0 (en) 2014-08-03
ZA201404246B (en) 2016-10-26
BR112014014604A2 (pt) 2017-06-13
MX342273B (es) 2016-09-21
EP2791129B1 (en) 2015-10-07
GB201121557D0 (en) 2012-01-25
HRP20151422T1 (hr) 2016-02-26
CA2859281C (en) 2020-10-27
ME02348B (me) 2016-06-20
ES2557762T3 (es) 2016-01-28
MX2014007129A (es) 2014-09-04
DK2791129T3 (en) 2015-12-14
JP2018008985A (ja) 2018-01-18
AU2012351341A1 (en) 2014-07-24
RS54523B1 (sr) 2016-06-30
SMT201500327B (it) 2016-02-25
CN104114548B (zh) 2016-01-20
BR112014014604B1 (pt) 2021-01-12
EA026617B1 (ru) 2017-04-28
JP6300277B2 (ja) 2018-03-28
UA111868C2 (uk) 2016-06-24
HK1197671A1 (zh) 2015-02-06
PT2791129E (pt) 2016-01-26
JP2015500325A (ja) 2015-01-05
SG11201402798RA (en) 2014-06-27
IL233132A (en) 2015-09-24
HUE028257T2 (en) 2016-12-28
US9102658B2 (en) 2015-08-11
AU2012351341B2 (en) 2017-08-24
EP2791129A1 (en) 2014-10-22
CN104114548A (zh) 2014-10-22
NZ626732A (en) 2015-09-25
EA201490998A1 (ru) 2014-11-28

Similar Documents

Publication Publication Date Title
HRP20181696T1 (hr) Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline
IL233413A (en) Methods for Producing Acrylic Pinkol Acid 4-Chloro-2-Fluoro-3-Converted-Phenylboron
IL235802A0 (en) A new process for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid
SG11201400939YA (en) Process for the preparation of methoxymelonal
IL233132A0 (en) Process for the preparation of esters of 5-fluoro-2-methyl-3-quinoline-2-ylmethylindol-1-yl-acetic acid
IL231645A (en) Process for making isoxazolyl - methoxy - nicotinic acids
SG2014012587A (en) Process for preparation of methacrylic acid and methacrylic acid esters
LT2931696T (lt) Nepertraukiamas (s)-2-acetiloksipropiono rūgšties gamybos būdas
IL227317A0 (en) A process for the preparation of pyrazole carboxylic acid amide
PL2780323T3 (pl) Sposób otrzymywania kwasu chinolinokarboksylowego
SG2014012637A (en) Process for preparation of methacrylic acid and methacrylic acid ester
SG2014012561A (en) Process for preparation of methacrylic acid and methacrylic acid esters
EP2755991A4 (en) PROCESS FOR THE PREPARATION OF BETULINIC ACID
PL2755990T3 (pl) Sposób otrzymywania kwasu betulinowego
PL2755989T3 (pl) Sposób wytwarzania kwasu betulinowego
PL2398779T3 (pl) Nowy sposób wytwarzania kwasu nitroorotowego
SG11201402888UA (en) Process for the manufacture of acetic acid
SG11201402858PA (en) Process for the manufacture of acetic acid
GB2503103B8 (en) Process for the production of fatty acid esters
PL2673282T3 (pl) Nowy sposób wytwarzania kwasów dronowych
PL390748A1 (pl) Sposób otrzymywania kwasu akrylowego
PL390162A1 (pl) Sposób otrzymywania kwasu akrylowego
IL229602A0 (en) Method for the production of fluoromethyl esters of androstene-17-beta carboxylic acids
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny